UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Blood Glucose Management by Continuous Glucose Monitoring (CGM) and New Indicators

Journal of the Japan Diabetes Society, 2023/03/30, Vol.66(3), pp.190-193

Toyoda, Masao

2023

Volltextzugriff (PDF)

Epithelial-Mesenchymal Transition as a Potential Explanation for Podocyte Depletion in Diabetic Nephropathy

American journal of kidney diseases, 2009-10, Vol.54 (4), p.653-664

2009

Volltextzugriff (PDF)

Clinical Phenotypes and the Clinical Course of Bullous Pemphigoid Receiving Dipeptidyl Pepitidase-4 Inhibitor Treatment: An Analysis of Cases in a Single Japanese Center

Internal Medicine, 2023/06/15, Vol.62(12), pp.1715-1722

2023

Volltextzugriff (PDF)

Podocyte Detachment and Reduced Glomerular Capillary Endothelial Fenestration in Human Type 1 Diabetic Nephropathy

Diabetes (New York, N.Y.), 2007-08, Vol.56 (8), p.2155-2160

2007

Volltextzugriff (PDF)

Relationship between Serum Antioxidative Vitamin Concentrations and Type 2 Diabetes in Japanese Subjects

Journal of Nutritional Science and Vitaminology, 2020/08/31, Vol.66(4), pp.289-295

2020

Volltextzugriff (PDF)

Comparison of the blood pressure management between sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists

Scientific reports, 2022-09, Vol.12 (1), p.16106-16106, Article 16106

2022

Volltextzugriff (PDF)

Evaluation of ABCG2-mediated extra-renal urate excretion in hemodialysis patients

Scientific reports, 2023-01, Vol.13 (1), p.93-93, Article 93

2023

Volltextzugriff (PDF)

Atypical Ketoacidosis and Protracted Hyperglycosuria after Treatment with Ipragliflozin, an SGLT2 Inhibitor

Internal Medicine, 2017/07/01, Vol.56(13), pp.1673-1678

2017

Volltextzugriff (PDF)

Sodium–glucose cotransporter 2 inhibitor‐induced reduction in the mean arterial pressure improved renal composite outcomes in type 2 diabetes mellitus patients with chronic kidney disease: A propensity score‐matched model analysis in Japan

Journal of diabetes investigation, 2021-08, Vol.12 (8), p.1408-1416

2021

Volltextzugriff (PDF)

Concomitant treatment with insulin and sodium–glucose cotransporter 2 inhibitors was associated with the renal composite outcome in Japanese patients with type 2 diabetes and chronic kidney disease: A propensity score‐matched analysis

Journal of diabetes investigation, 2022-09, Vol.13 (9), p.1520-1527

2022

Volltextzugriff (PDF)

Factors associated with hemoglobin glycation index in adults with type 1 diabetes mellitus: The FGM‐Japan study

Journal of diabetes investigation, 2023-04, Vol.14 (4), p.582-590

2023

Volltextzugriff (PDF)

A variant within the FTO confers susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes

PloS one, 2018-12, Vol.13 (12), p.e0208654-e0208654

2018

Volltextzugriff (PDF)

Predictive Factors of the Adherence to Real-Time Continuous Glucose Monitoring Sensors: A Prospective Observational Study (PARCS STUDY)

Journal of diabetes science and technology, 2021-09, Vol.15 (5), p.1084-1092

2021

Volltextzugriff (PDF)

Comparison of renal outcomes between sodium glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists

Diabetes research and clinical practice, 2022-03, Vol.185, p.109231-109231, Article 109231

2022

Volltextzugriff (PDF)

Nivolumab‐induced fulminant type 1 diabetes with precipitous fall in C‐peptide level

Journal of diabetes investigation, 2020-05, Vol.11 (3), p.748-749

2020

Volltextzugriff (PDF)

Renoprotective effect of long acting thioredoxin by modulating oxidative stress and macrophage migration inhibitory factor against rhabdomyolysis-associated acute kidney injury

Scientific reports, 2015-09, Vol.5 (1), p.14471, Article 14471

2015

Volltextzugriff (PDF)

The Current Intermittent-Scanning CGM Device Situation in Japan: Only Adjunctive Use to SMBG Is Approved and the Latest Health Insurance Coverage Details

Journal of diabetes science and technology, 2018-05, Vol.12 (3), p.729-730

2018

Volltextzugriff (PDF)

893-P: Relation between Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists and Renal Functions among Japanese Diabetics

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

892-P: Influence of Preceding Medications on the Renal Outcomes of Japanese Diabetics Treated with SGLT2 Inhibitors and GLP-1 Receptor Agonists

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

Effects of Liraglutide, a Human Glucagon-like Peptide-1 Analogue, on Body Weight, Body Fat Area and Body Fat-related Markers in Patients with Type 2 Diabetes Mellitus

Internal Medicine, 2013, Vol.52(10), pp.1029-1034

2013

Volltextzugriff (PDF)

Caution is required for the evaluation of the accuracy of continuous glucose monitoring devices

Journal of diabetes investigation, 2020-01, Vol.11 (1), p.255-255

2020

Volltextzugriff (PDF)

The Adjunctive Use of FreeStyle Libre to SMBG is Still Important in Japan

Journal of the Japan Diabetes Society, 2020/09/30, Vol.63(9), pp.634-635

2020

Volltextzugriff (PDF)

Predictors of response to liraglutide in Japanese type 2 diabetes

Diabetes research and clinical practice, 2014-12, Vol.106 (3), p.451-457

2014

Volltextzugriff (PDF)

Study of the Effects of Deuterium-Depleted Water on the Expression of GLUT4 and Insulin Resistance in the Muscle Cell Line C2C12

Biomedicines, 2024-08, Vol.12 (8), p.1771

2024

Volltextzugriff (PDF)

Assessment of the accuracy of an intermittent‐scanning continuous glucose monitoring device in patients with type 2 diabetes mellitus undergoing hemodialysis (AIDT2H) study

Therapeutic apheresis and dialysis, 2021-10, Vol.25 (5), p.586-594

2021

Volltextzugriff (PDF)

1 – 25 von 923

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(406)
Mit Volltextzugriff
(720)

Publikationsform

Sprache

Englisch
(679)
Japanisch
(328)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Blood Glucose Management by Continuous Glucose Monitoring (CGM) and New Indicators

Epithelial-Mesenchymal Transition as a Potential Explanation for Podocyte Depletion in Diabetic Nephropathy

Clinical Phenotypes and the Clinical Course of Bullous Pemphigoid Receiving Dipeptidyl Pepitidase-4 Inhibitor Treatment: An Analysis of Cases in a Single Japanese Center

Podocyte Detachment and Reduced Glomerular Capillary Endothelial Fenestration in Human Type 1 Diabetic Nephropathy

Relationship between Serum Antioxidative Vitamin Concentrations and Type 2 Diabetes in Japanese Subjects

Comparison of the blood pressure management between sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists

Evaluation of ABCG2-mediated extra-renal urate excretion in hemodialysis patients

Atypical Ketoacidosis and Protracted Hyperglycosuria after Treatment with Ipragliflozin, an SGLT2 Inhibitor

Sodium–glucose cotransporter 2 inhibitor‐induced reduction in the mean arterial pressure improved renal composite outcomes in type 2 diabetes mellitus patients with chronic kidney disease: A propensity score‐matched model analysis in Japan

Concomitant treatment with insulin and sodium–glucose cotransporter 2 inhibitors was associated with the renal composite outcome in Japanese patients with type 2 diabetes and chronic kidney disease: A propensity score‐matched analysis

Factors associated with hemoglobin glycation index in adults with type 1 diabetes mellitus: The FGM‐Japan study

A variant within the FTO confers susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes

Predictive Factors of the Adherence to Real-Time Continuous Glucose Monitoring Sensors: A Prospective Observational Study (PARCS STUDY)

Comparison of renal outcomes between sodium glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists

Nivolumab‐induced fulminant type 1 diabetes with precipitous fall in C‐peptide level

Renoprotective effect of long acting thioredoxin by modulating oxidative stress and macrophage migration inhibitory factor against rhabdomyolysis-associated acute kidney injury

The Current Intermittent-Scanning CGM Device Situation in Japan: Only Adjunctive Use to SMBG Is Approved and the Latest Health Insurance Coverage Details

893-P: Relation between Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists and Renal Functions among Japanese Diabetics

892-P: Influence of Preceding Medications on the Renal Outcomes of Japanese Diabetics Treated with SGLT2 Inhibitors and GLP-1 Receptor Agonists

Effects of Liraglutide, a Human Glucagon-like Peptide-1 Analogue, on Body Weight, Body Fat Area and Body Fat-related Markers in Patients with Type 2 Diabetes Mellitus

Caution is required for the evaluation of the accuracy of continuous glucose monitoring devices

The Adjunctive Use of FreeStyle Libre to SMBG is Still Important in Japan

Predictors of response to liraglutide in Japanese type 2 diabetes

Study of the Effects of Deuterium-Depleted Water on the Expression of GLUT4 and Insulin Resistance in the Muscle Cell Line C2C12

Assessment of the accuracy of an intermittent‐scanning continuous glucose monitoring device in patients with type 2 diabetes mellitus undergoing hemodialysis (AIDT2H) study

Suchergebnisse filtern